Immunome (IMNM) News Today → Protect Your Bank Account Before It’s Too Late (From Weiss Ratings) (Ad) Free IMNM Stock Alerts $15.20 +0.05 (+0.33%) (As of 06/7/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 8 at 8:14 AM | americanbankingnews.comImmunome (NASDAQ:IMNM) Shares Down 4.2% June 7 at 1:26 AM | americanbankingnews.comAnalysts Set Immunome, Inc. (NASDAQ:IMNM) Price Target at $29.80June 4, 2024 | marketbeat.comImmunome, Inc. (NASDAQ:IMNM) Given Average Recommendation of "Buy" by BrokeragesShares of Immunome, Inc. (NASDAQ:IMNM - Get Free Report) have earned an average recommendation of "Buy" from the seven ratings firms that are currently covering the company, MarketBeat.com reports. Seven analysts have rated the stock with a buy rating. The average 12 month target price among analyJune 3, 2024 | marketbeat.comMayo Clinic Acquires New Position in Immunome, Inc. (NASDAQ:IMNM)Mayo Clinic bought a new position in shares of Immunome, Inc. (NASDAQ:IMNM - Free Report) during the 4th quarter, according to the company in its most recent filing with the SEC. The fund bought 108,480 shares of the company's stock, valued at approximately $1,161,000. Immunome accounts for aboutJune 1, 2024 | americanbankingnews.comImmunome (NASDAQ:IMNM) Research Coverage Started at Piper SandlerMay 31, 2024 | marketbeat.comImmunome (NASDAQ:IMNM) Shares Gap Up to $14.71Immunome (NASDAQ:IMNM) Shares Gap Up to $14.71May 24, 2024 | msn.comImmunome (NASDAQ:IMNM): An Opportunity for Investors with Strong StomachsMay 23, 2024 | insidertrades.comInsider Buying: Immunome, Inc. (NASDAQ:IMNM) Director Buys 2,000 Shares of StockMay 22, 2024 | marketbeat.comInsider Buying: Immunome, Inc. (NASDAQ:IMNM) Director Purchases 2,000 Shares of StockImmunome, Inc. (NASDAQ:IMNM - Get Free Report) Director Jean Jacques Bienaime acquired 2,000 shares of the business's stock in a transaction dated Tuesday, May 21st. The shares were bought at an average cost of $13.57 per share, for a total transaction of $27,140.00. Following the transaction, the director now directly owns 9,615 shares in the company, valued at $130,475.55. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.May 22, 2024 | marketbeat.comImmunome (NASDAQ:IMNM) Shares Gap Up to $13.65Immunome (NASDAQ:IMNM) Shares Gap Up to $13.65May 21, 2024 | finance.yahoo.comInsider Buying: Immunome Inc's CEO Acquires 100,000 SharesMay 20, 2024 | businesswire.comImmunome Announces Completion of Purchase of Assets from AtrecaMay 17, 2024 | marketbeat.comImmunome (NASDAQ:IMNM) Stock Price Down 4%Immunome (NASDAQ:IMNM) Shares Down 4%May 17, 2024 | msn.comImmunome appoints CFOMay 17, 2024 | marketbeat.comImmunome, Inc. to Post FY2024 Earnings of ($0.76) Per Share, Leerink Partnrs Forecasts (NASDAQ:IMNM)Immunome, Inc. (NASDAQ:IMNM - Free Report) - Investment analysts at Leerink Partnrs boosted their FY2024 earnings per share estimates for shares of Immunome in a research note issued on Tuesday, May 14th. Leerink Partnrs analyst A. Berens now expects that the company will post earnings of ($0.76)May 17, 2024 | businesswire.comImmunome Announces Promotion of Max Rosett to Chief Financial OfficerMay 16, 2024 | markets.businessinsider.comImmunome’s Promising Pipeline and Strategic Positioning Affirm Buy RatingMay 16, 2024 | marketbeat.comQ2 2024 Earnings Forecast for Immunome, Inc. (NASDAQ:IMNM) Issued By WedbushImmunome, Inc. (NASDAQ:IMNM - Free Report) - Analysts at Wedbush lowered their Q2 2024 earnings estimates for shares of Immunome in a report released on Tuesday, May 14th. Wedbush analyst D. Nierengarten now forecasts that the company will post earnings per share of ($0.57) for the quarter, downMay 15, 2024 | marketbeat.comImmunome (NASDAQ:IMNM) Shares Up 5.6%Immunome (NASDAQ:IMNM) Shares Up 5.6%May 14, 2024 | marketbeat.comImmunome's (IMNM) "Outperform" Rating Reaffirmed at WedbushWedbush reissued an "outperform" rating and set a $33.00 price target on shares of Immunome in a research report on Tuesday.May 14, 2024 | investorplace.comIMNM Stock Earnings: Immunome Beats EPS, Misses Revenue for Q1 2024May 14, 2024 | marketbeat.comImmunome (NASDAQ:IMNM) Shares Gap Down to $15.61Immunome (NASDAQ:IMNM) Shares Gap Down to $15.61May 14, 2024 | markets.businessinsider.comImmunome, Inc. Q1 Loss Increases, Misses EstimatesMay 14, 2024 | businesswire.comImmunome Reports First Quarter 2024 Financial Results and Provides Business UpdateMay 8, 2024 | businesswire.comImmunome to Present at 2024 Bank of America Healthcare ConferenceMay 2, 2024 | businesswire.comImmunome Appoints Kinney Horn as Chief Business OfficerApril 30, 2024 | marketbeat.comImmunome (NASDAQ:IMNM) Shares Gap Up to $13.82Immunome (NASDAQ:IMNM) Shares Gap Up to $13.82April 25, 2024 | businesswire.comImmunome Appoints Sandra M. Swain to Board of DirectorsApril 24, 2024 | marketbeat.com61,346 Shares in Immunome, Inc. (NASDAQ:IMNM) Acquired by Cerity Partners LLCCerity Partners LLC purchased a new stake in Immunome, Inc. (NASDAQ:IMNM - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 61,346 shares of the company's stock, valueApril 22, 2024 | marketbeat.comImmunome (NASDAQ:IMNM) Shares Gap Up to $15.48Immunome (NASDAQ:IMNM) Shares Gap Up to $15.48April 19, 2024 | finance.yahoo.comImmunome, Inc. (IMNM)April 17, 2024 | msn.comImmunome (IMNM) Price Target Increased by 8.72% to 36.04April 16, 2024 | msn.comGuggenheim Initiates Coverage of Immunome (IMNM) with Buy RecommendationApril 15, 2024 | marketbeat.comEmfo LLC Buys Shares of 59,165 Immunome, Inc. (NASDAQ:IMNM)Emfo LLC bought a new stake in Immunome, Inc. (NASDAQ:IMNM - Free Report) during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 59,165 shares of the company's stock, valued at approximately $633,000. Emfo LLC owned approximately 0.14% ofApril 15, 2024 | marketbeat.comImmunome, Inc. (NASDAQ:IMNM) Given Average Rating of "Buy" by BrokeragesShares of Immunome, Inc. (NASDAQ:IMNM - Get Free Report) have received a consensus rating of "Buy" from the five ratings firms that are presently covering the firm, Marketbeat reports. Five analysts have rated the stock with a buy recommendation. The average 12 month price target among brokers thaApril 5, 2024 | businesswire.comImmunome to Present Preclinical Data for IM-3050, Its Lead Radioligand Therapy Candidate, at 2024 American Association for Cancer Research (AACR) Annual MeetingApril 4, 2024 | marketbeat.comImmunome (NASDAQ:IMNM) Trading Down 4.5%Immunome (NASDAQ:IMNM) Trading Down 4.5%April 4, 2024 | marketbeat.comQ1 2024 EPS Estimates for Immunome, Inc. (NASDAQ:IMNM) Reduced by WedbushImmunome, Inc. (NASDAQ:IMNM - Free Report) - Stock analysts at Wedbush dropped their Q1 2024 earnings estimates for shares of Immunome in a research note issued on Monday, April 1st. Wedbush analyst D. Nierengarten now anticipates that the company will earn ($0.52) per share for the quarter, downApril 3, 2024 | marketbeat.comWedbush Weighs in on Immunome, Inc.'s Q1 2025 Earnings (NASDAQ:IMNM)Immunome, Inc. (NASDAQ:IMNM - Free Report) - Investment analysts at Wedbush issued their Q1 2025 earnings estimates for shares of Immunome in a research report issued on Monday, April 1st. Wedbush analyst D. Nierengarten anticipates that the company will post earnings of ($0.78) per share for theApril 1, 2024 | marketbeat.comImmunome (NASDAQ:IMNM) Given New $33.00 Price Target at WedbushWedbush lifted their target price on shares of Immunome from $27.00 to $33.00 and gave the stock an "outperform" rating in a research note on Monday.March 29, 2024 | marketbeat.comLeerink Partnrs Weighs in on Immunome, Inc.'s Q1 2024 Earnings (NASDAQ:IMNM)Immunome, Inc. (NASDAQ:IMNM - Free Report) - Leerink Partnrs lifted their Q1 2024 EPS estimates for Immunome in a research note issued to investors on Tuesday, March 26th. Leerink Partnrs analyst A. Berens now forecasts that the company will post earnings per share of ($1.71) for the quarter, upMarch 29, 2024 | investorplace.comIMNM Stock Earnings: Immunome Beats EPS, Beats Revenue for Q4 2023March 28, 2024 | markets.businessinsider.comTD Cowen Reaffirms Their Buy Rating on Immunome (IMNM)March 28, 2024 | marketbeat.comImmunome (NASDAQ:IMNM) Shares Down 3.7% Immunome (NASDAQ:IMNM) Stock Price Down 3.7%March 28, 2024 | businesswire.comImmunome Reports Full Year 2023 Financial Results and Provides Update on Recently Acquired AssetsMarch 28, 2024 | businesswire.comImmunome Reports Full Year 2023 Financial Results and Provides Update on Recently Acquired AssetsMarch 27, 2024 | finance.yahoo.comImmunome Completes Acquisition of AL102, a Phase 3 Asset for the Treatment of Desmoid Tumors, From AyalaMarch 26, 2024 | marketbeat.comImmunome (NASDAQ:IMNM) Shares Up 5.3%Immunome (NASDAQ:IMNM) Trading Up 5.3%March 22, 2024 | finance.yahoo.comImmunome, Inc. (NASDAQ:IMNM) surges 7.6%; individual investors who own 42% shares profited along with institutionsMarch 20, 2024 | marketbeat.comImmunome (NASDAQ:IMNM) Trading Down 5%Immunome (NASDAQ:IMNM) Shares Down 5% Get Immunome News Delivered to You Automatically Sign up to receive the latest news and ratings for IMNM and its competitors with MarketBeat's FREE daily newsletter. Email Address Was the Great Financial Crisis fun? (Ad)The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, was terrible! The majority of market indexes lost over 50% of their value. Almost every day, traders would look at their trading accounts and just see a sea of red. Get those kind of results during the Great Financial Crisis, without having to study more IMNM Media Mentions By Week IMNM Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IMNM News Sentiment▼0.820.73▲Average Medical News Sentiment IMNM News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IMNM Articles This Week▼42▲IMNM Articles Average Week Get Immunome News Delivered to You Automatically Sign up to receive the latest news and ratings for IMNM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: IGMS News Today VIR News Today CRNX News Today AXSM News Today CORT News Today RARE News Today PBH News Today MRUS News Today HCM News Today IDYA News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IMNM) was last updated on 6/8/2024 by MarketBeat.com Staff From Our PartnersCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredNvidia’s Quiet $1 Trillion PivotNvidia recently added $277 billion in market cap … IN ONE DAY.Weiss Ratings | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | Sponsored25% of Americans Are In Grave DangerAccording to this White House briefing … AI will replace up to 300 million jobs. That would amount to 25% of A...Banyan Hill Publishing | SponsoredWas the Great Financial Crisis fun?The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, ...Brooks Enterprises | Sponsored